Net revenue, excluding traffic acquisition costs, or TAC, came in at $1.08 billion during the third quarter. That was down 1% from a year earlier when Yahoo generated $1.09 billion in net revenue.
Earnings came in at 34 cents a share, compared to 39 cents a share a year earlier, the company also said.
Yahoo was expected to make 33 cents a share on revenue of $1.08 billion in the period, according to Thomson Reuters data.
Marissa Mayer has righted the ship since joining Yahoo about 15 months ago ��spurring a major recovery in its shares, which have more than doubled in the period.
Top 5 Insurance Companies To Watch For 2015: LoJack Corporation(LOJN)
LoJack Corporation provides technology products and services for the tracking and recovery of mobile assets, stolen vehicles, motorcycles, construction equipment, cargo, and people at risk. It offers LoJack Unit, a LoJack System component that consists of a high frequency transponder with a hidden antenna, microprocessor, and power supply, as well as a set of codes unique to the unit; and LoJack Early Warning Unit, an optional component that provides notification to vehicle owners in the event of unauthorized user operating the vehicle. The company also licenses LoJack for Laptops, a system to recover the stolen computers; and LoJack InTransit, a cargo and tracking recovery solution. In addition, it provides LoJack SafetyNet system, which comprises a personal locator unit, a search and rescue receiver used by public safety agencies. The company markets its products to owners of commercial equipment and to consumers through its sales force, telemarketing representatives, di rect mail, and automobile dealers. It operates in the United States, Africa, Latin America, the Caribbean countries, Canada, and Europe. LoJack Corporation was founded in 1978 and is headquartered in Canton, Massachusetts.
Advisors' Opinion:- [By Wallace Witkowski]
Shares of LoJack Corp. (LOJN) �surged 20% to $5.30 on moderate volume after the car-security-system company said an arbitration panel dismissed claims by a Brazilian licensee over a contract dispute.
Top 10 Net Payout Yield Stocks For 2014: AmerisourceBergen Corp (ABC)
AmerisourceBergen Corporation (AmerisourceBergen), incorporated on March 16, 2001, is a pharmaceutical services companies serving the United States, Canada, and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. The Company distributes a range of pharmaceuticals (including specialty pharmaceutical products), generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. The Company also provides pharmacy services to certain specialty drug patients. In addition, the Company furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including pharmacy automation, inventories management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. The Company serves its customers (healthcare providers, pharmaceutical manufacturers, and specialty drug patients) through a network of distribution service centers and other operations in the United States, Canada, and global markets. In the Company's pharmaceutical distribution business, the Company is a source of supply of pharmaceutical and related products to its healthcare provider customers.
As of September 30, 2012, the Company's operations were comprised of the Pharmaceutical Distribution reportable segment and Other. Other consists of the AmerisourceBergen Consulting Services (ABCS) and World Courier operating segments. In September 2011, the Company acquired IntrinsiQ, LLC (IntrinsiQ) and Premier Source! . IntrinsiQ is a provider of informatics solutions, which help community oncologists make treatment decisions for their patients. Premier Source is a provider of consulting and reimbursement services to medical device, pharmaceutical, molecular diagnostic, and biotechnology manufacturers, as well as other health services companies. On November 1, 2011, the Company acquired TheraCom, LLC (TheraCom). TheraCom is a provider of commercialization support services to the biotechnology and pharmaceutical industry, including reimbursement and patient access support services. On April 30, 2012, the Company acquired World Courier Group, Inc. (World Courier), which is a global specialty transportation and logistics provider for the biopharmaceutical industry.
Pharmaceutical Distribution Segment
The Pharmaceutical Distribution reportable segment is consisted of two operating segments, which include the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG). Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. ABDC distributes a offering of brand-name pharmaceuticals (including specialty pharmaceutical products) and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. ABDC also provides pharmacy management, staffing and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets, and supply management software to a range of retail and institutional healthcare providers. In addition, ABDC delivers packaging solutions to institutional and retail healthcare providers.!
ABSG, through a range of operating businesses, provides pharmaceutical distribution and other services to physicians who specialize in a range of disease states, especially oncology, and to other healthcare providers, including dialysis clinics. ABSG also distributes plasma and other blood products, injectible pharmaceuticals and vaccines. In addition, ABSG provides third party logistics and other services for biotechnology and other pharmaceutical manufacturers. The Company's use of the term specialty and specialty pharmaceutical products refers to drugs used to treat complex diseases, such as cancer, diabetes, and multiple sclerosis. Specialty pharmaceutical products are part of complex treatment regimens for serious conditions and diseases, which require ongoing clinical monitoring.
Other
ABCS, through a number of operating businesses, provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and copay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers. World Courier, which operates in over 50 countries, is a specialty transportation and logistics provider for the biopharmaceutical industry. As of September 30, 2012, the Company committed to a plan to divest AndersonBrecon.
The Company competes with Cardinal Health, Inc., McKesson Corporation, FFF Enterprises, Henry Schein, Inc. and UPS Logistics.
Advisors' Opinion:- [By DAILYFINANCE]
Russel A. Daniels/AP Walgreen Co.'s fiscal fourth-quarter earnings soared 86 percent, as the nation's largest drugstore chain booked gains from its method of inventory accounting and its acquisition of a stake in European health and beauty retailer Alliance Boots. The Deerfield, Ill., company said Tuesday that it earned $657 million, or 69 cents a share, in the quarter that ended Aug. 31. That compares with earnings of $353 million, or 39 cents a share, a year ago. Revenue climbed 5 percent to $17.94 billion. Adjusted earnings totaled 73 cents a share, excluding acquisition-related costs among other items. Analysts forecast earnings of 72 cents a share on $17.96 billion in revenue, according to FactSet. Walgreen (WAG) shares slipped 15 cents to $53.65 Tuesday before markets opened and after the company announced results. Walgreen recorded an $8 million "last-in-first-out" inventory benefit in this year's quarter, compared with a $132 million charge last year. LIFO is a method of accounting for inventory that assumes a company sells its newest inventory first. The company takes a credit or charge each quarter according to the anticipated inflation rate for the year. The company attributed the big swing to lower-than-anticipated prescription drug inventory ahead of a transition it made to AmerisourceBergen Corp. (ABC). Walgreen had announced earlier this year that it and Alliance Boots were buying an ownership stake in drug distributor AmerisourceBergen Corp. Walgreen also entered into a supply agreement with AmerisourceBergen for its drugstores, mail order and specialty pharmacy businesses. Last year, Walgreen acquired a 45 percent stake in Swiss-based Alliance Boots for about $4 billion in cash plus 83.4 million Walgreen shares. Walgreen then booked $124 million in equity earnings from its stake in this year's quarter. Walgreen runs the nation's largest chain of drugstores, with 8,116 locations nationwide. The company said an influx of generic drugs a
- [By Dividend King]
Amerisource Bergen (ABC) offers packaging and distribution services to drugs manufacturers across the U.S. and Canada.
Its shares are currently trading around $39, and the mean 12 month price target from analysts researching the stock is $45.33 (17% upside potential). This stock is trading above its 50-day exponential moving average of $38.40 and its 200-day exponential moving average of $38.25. The 50-day EMA has recently moved above the 200-day EMA, a potentially bullish indicator. There is good, solid support for the shares at around $35, though the low over the last 52 weeks is 34.33: a level from which there was an extremely strong bounce in August.
- [By Marc Bastow]
Pharmaceuticals company AmerisourceBergen (ABC) raised its dividend 12% to 23.5 cents per share, payable on Dec. 2 to shareholders of record as of Nov. 18.
ABC Dividend Yield:
Top 10 Net Payout Yield Stocks For 2014: Remy Cointreau SA (RCO)
Remy Cointreau SA is a France-based company engaged in the production and distribution of wines and spirits. The Company's activities are divided into two segments. Cognac, which offers a range of products under the Remy Martin brand and Liqueurs and Spirits, distributing liquors under the Cointreau, Izarra and Passoa brand names, as well as spirits under such brand names as Mount Gay (rum), St Remy (brandy), Ponche Kuna (rum) and Metaxa (brandy). The Company is a sole distributor of the Piper-Heidsieck and Charles Heidsieck brands, as well as Piper Sonoma (the sparkling wine brand). The Company's subsidiaries include production companies, such as E. Remy Martin & Cie, and distribution companies, such as Remy Cointreau USA Inc. In August 2013, it completed the sale of Larsen Cognac to the Finnish group Altia. Advisors' Opinion:- [By Inyoung Hwang]
Remy Cointreau SA (RCO) jumped 6 percent, the most since January. Chinese cognac shipments increased 20.5 percent in August, rising for the first time since January, according to UBS AG, citing from BNIC, a trade association of cognac makers.
Top 10 Net Payout Yield Stocks For 2014: Adams Golf Inc.(ADGF)
Adams Golf, Inc., together with its subsidiaries, designs, assembles, markets, and distributes golf clubs for various skill levels primarily in the United States and internationally. Its products comprise Speedline Fast 12 drivers, Fast 12 LS drivers, Speedline Fast 12 fairway woods, Idea a12 OS irons and hybrids, Idea a12 hybrids, Idea Pro a12 irons and hybrids, Idea Tech V3 irons and hybrids, Redline irons, Idea a7 and a7 OS irons and hybrids, and Speedline 9088 UL drivers. It also develops products under the Yes! Putters, Women's Golf Unlimited, Lady Fairway, and Square 2 brands. In addition, it offers a range of golf bags, hats, and other accessories. The company sells its products to on- and off- course golf shops, sporting goods retailers, and mass merchants, as well as to international distributors. Adams Golf, Inc. was founded in 1987 and is based in Plano, Texas.
Advisors' Opinion:- [By Geoff Gannon]
Adams Golf (ADGF) was a net-net. It got bought out by Adidas. By the way, it�� not the only net-net to get bought out this year. Swank (SNKI) was also a net-net that looks like it�� going to be bought out. Last I heard, they received an alternative proposal during their ��o shop��period and haven�� acted on it. The Ben Graham: Net-Net Newsletter�� model portfolio doesn�� own either stock. Though we do own another net-net where a company in the same industry bought a block of shares. Who knows what that means. But clearly net-nets sometimes attract control buyers.
Top 10 Net Payout Yield Stocks For 2014: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX Line
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
BROVEX Line
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX Line
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Line
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
PEDIATEX Line
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST Line
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV). - [By Michael Douglass and David Williamson]
Shares of�Pernix Therapeutics� (NASDAQ: PTX ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to�GlaxoSmithKline's (NYSE: GSK ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix -- the company had $85 million in revenue last year, while Treximet on its own brought in $79 million -- and Pernix clearly sees some additional upside potential for the drug, whether it's through a potential indication expansion (to pediatric patients) or through synergies with Pernix's current salesforce.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent. - [By John Udovich]
Since the start of 2014, small cap pharmaceutical stocks�Achillion Pharmaceuticals, Inc (NASDAQ: ACHN), Pernix Therapeutics Holdings Inc (NASDAQ: PTX) and Amicus Therapeutics, Inc (NASDAQ: FOLD)�are up 286.3%, 262.3% and 248.1%, respectively, making them some of the best performing pharmaceutical stocks for the year. However, a one year share performance, especially for anything in the volatile biotech or pharmaceutical sector, could be just a one time fluke. With that in mind, here is what you need to know or be warned about all three small cap pharmaceutical stocks:
Top 10 Net Payout Yield Stocks For 2014: Five Star Quality Care Inc (FVE)
Five Star Quality Care, Inc. (Five Star), incorporated in April 2000, operates senior living communities, including independent living communities, assisted living communities and skilled nursing facilities (SNFs). As of December 31, 2011, the Company operated 245 senior living communities located in 30 states containing 27,159 living units, including 207 primarily independent and assisted living communities with 23,736 living units and 38 SNFs with 3,423 living units. The Company owns and operates 31 communities (2,954 living units), lease and operate 191 communities (20,811 living units), and manage 23 communities (3,394 living units). Its 245 senior living communities included 8,699 independent living apartments, 13,069 assisted living suites and 5,391 skilled nursing units. During the year ended December 31, 2011, the Company discontinued its operations on two SNFs owned and operated by it containing 271 living units and one assisted living community leased from Senior Housing Properties Trust (SNH) and operated by it containing 103 living units. In September 2012, it sold its pharmacy business to Omnicare, Inc. Effective December 31, 2013, Five Star transferred the operations of two rehabilitation hospitals, which included New England Rehabilitation Hospital located in Woburn and Braintree Rehabilitation Hospital located in Braintree, to entities affiliated with Reliant Hospital Partners, LLC.
As of December 31, 2011, the Company leased and operated two rehabilitation hospitals with 321 beds that provide inpatient rehabilitation services to patients at the two hospitals and at three satellite locations. In addition, it leased and operated 13 outpatient clinics affiliated with these rehabilitation hospitals. It also owns and operate five institutional pharmacies. In 2011, the Company acquired from unrelated parties seven assisted living communities containing 854 living units with one located in Arizona and the other six located in Indiana, or the Indiana Communities. It also commenc! ed leasing from SNH six senior living communities containing 724 living units with one located in each of Illinois and Florida and two located in each of North Carolina and Virginia.
Independent Living Communities
Independent living communities provide privacy to residents and require residents to be capable of independence. An independent living apartment usually bundles several services as part of a regular monthly charge. In addition, services are available from staff employees on a fee for service basis. As of December 31, 2011, its business included 8,699 independent living apartments in 75 communities that it operated or managed.
Assisted Living Communities
Assisted living communities consists of one bedroom units which include private bathrooms and kitchens. Services bundled within one charge usually include three meals per day in a central dining room, daily housekeeping, laundry, medical reminders and around the clock availability of assistance with the activities of daily living such as dressing and bathing. Professional nursing and healthcare services are usually available at the community as requested or at regularly scheduled times. As of December 31, 2011, its business included 13,069 assisted living suites in 185 communities that it operated or managed. .
Skilled Nursing Facilities
SNFs provide nursing and healthcare services similar to those available in hospitals. A purpose built SNF includes one or two beds per room with a separate bathroom in each room and shared dining facilities. SNFs are staffed by licensed nursing professionals 24 hours per day. As of December 31, 2011, its business included 5,391 skilled nursing units in 69 communities.
Rehabilitation Hospitals
Rehabilitation hospitals, which are also known as inpatient rehabilitation facilities (IRFs), provide intensive physical therapy, occupational therapy and speech language pathology services. Patients in IRFs receive a mi! nimum of ! three hours of rehabilitation services daily. IRFs also provides radiology, laboratory, telemetry, hemodialysis and orthotics/prosthetics services. Outpatient satellite clinics are often included as part of the services offered by IRFs. As of December 31, 2011, its two rehabilitation hospitals had 321 beds available for inpatient services and provided rehabilitation services at the two hospitals and three satellite locations. In addition, it operates 13 outpatient clinics affiliated with its rehabilitation hospitals where patients discharged from hospitals can continue their therapy programs and receive amputee, brain injury, neurorehabilitation, cardio-pulmonary, orthopedic, spinal cord injury and stroke rehabilitation services.
Institutional Pharmacies
Institutional pharmacies provide drugs at locations where patients with recurring pharmacy requirements are concentrated. The Company�� five institutional pharmacies are located in six leased commercial spaces and one owned commercial building containing a total of approximately 67,759 square feet plus parking areas for its employees and delivery vehicles.
Advisors' Opinion:- [By Laura Brodbeck]
Tuesday
Earnings Expected From: Five Star Quality Care, Inc. (NYSE: FVE), Maximus, Inc. (NYSE: MMS), Nustar Energy (NYSE: NS), D.R. Horton, Inc. (NYSE: DHI), DISH Network Corporation (NASDAQ: DISH) Economic Releases Expected: German CPI, British CPI, British PPI, US Redbook, Indian manufacturing output, Indian industrial productionWednesday
Top 10 Net Payout Yield Stocks For 2014: Rent-A-Center Inc.(RCII)
Rent-A-Center, Inc., together with its subsidiaries, primarily engages in leasing household durable goods to customers on a rent-to-own basis. The company?s stores offer durable products, such as consumer electronics, appliances, computers, and furniture and accessories under flexible rental purchase agreements that allow the customer to obtain ownership of the merchandise at the conclusion of an agreed upon rental period. It also provides merchandise on an installment sales basis in its stores. As of December 31, 2010, the company operated 3,008 company-owned stores in the United States, and in Canada, Puerto Rico, and Mexico, including 42 retail installment sales stores under the names ?Get It Now? and ?Home Choice?; and 18 rent-to-own stores located in Canada under the ?Rent-A-Centre? name. It also operates 209 franchised rent-to-own stores in 32 states under the ColorTyme trade name; and 384 kiosk locations under the ?RAC Acceptance? model. In addition, the company, th rough its ColorTyme?s franchised stores, offers custom rims and tires for sale or rental under the trade names ?RimTyme? or ?ColorTyme Custom Wheels?. Rent-A-Center, Inc. was founded in 1986 and is headquartered in Plano, Texas.
Advisors' Opinion:- [By Garrett Cook]
Rent-A-Center (NASDAQ: RCII) shares tumbled 11.22 percent to $25.80 after the company issued a downbeat guidance for the second quarter. The company expected adjusted earnings of $0.36 to $0.38 per share on revenue of around $773 million.
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Rent-A-Center (NASDAQ: RCII) were down 21.51 percent to $24.51 on Q4 results.Apple (NASDAQ: AAPL) shares tumbled 7.80 percent to $507.55 after the company issued weak sales forecast for the second quarter and reported downbeat holiday iPhone sales.
- [By Garrett Cook]
Rent-A-Center (NASDAQ: RCII) shares tumbled 11.08 percent to $25.83 after the company issued a downbeat guidance for the second quarter. The company expected adjusted earnings of $0.36 to $0.38 per share on revenue of around $773 million.
- [By Wallace Witkowski]
Rent-A-Center Inc. (RCII) �shares dropped 9.3% to $26.35 on moderate volume after the company forecast second-quarter results below the Wall Street estimates, noting that ��m]acro-economic pressures continue to burden our financially constrained customers.��
No comments:
Post a Comment